![]() |
市場調查報告書
商品編碼
1884040
自動驗光儀和角膜曲率計市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測(2024-2032 年)Autorefractor and Keratometer Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
由於眼科疾病的增加、診斷設備的日益普及以及眼科醫療器材技術的創新,全球自動驗光儀和角膜曲率計市場持續穩定成長。 2024 年,該市場價值為 6,970 萬美元,預計到 2025 年將達到 7,330 萬美元。預計到 2032 年,該市場將進一步飆升至 1.071 億美元,反映了全球眼科診療業務的強勁成長。北美在 2024 年以 35% 的市佔率領先,這得益於先進的醫療基礎設施和主要公司不斷擴大的診斷設備產品組合。
市場概覽
自動驗光儀和角膜曲率計是重要的眼科診斷設備,分別用於測量屈光不正和角膜曲率。組合式自動驗光-角膜曲率計(ARK)可對遠視、近視、散光和其他屈光不正進行全面的視力評估。由於全球視力障礙負擔日益加重以及對早期檢測的日益重視,對這些設備的需求正在穩步增長。
市場由主要製造商支撐,包括拓普康公司、卡爾蔡司醫療技術股份公司、尼德克株式會社、佳能醫療系統和依視路陸遜梯卡集團,這些製造商都在大力投資技術創新和產品拓展策略。
市場驅動因素
眼科疾病的成長趨勢
散光、遠視和白內障等眼科疾病的盛行率正在加速上升。生活方式的改變、螢幕使用時間的增加以及與年齡相關的眼部退化,促使越來越多的人需要視力矯正。根據美國國家生物技術資訊中心 (NCBI) 2023 年 9 月發布的報告預測,到 2050 年,全球約 50% 的人口將患有近視,其中 10% 預計為高度近視。應對這一日益嚴重的負擔需要先進的眼科診斷解決方案,從而推動了對自動驗光儀和角膜曲率計的需求。
促進早期準確診斷
各國政府和醫療機構正在加大對早期檢測項目的投入,以控制可預防的失明。早期篩檢屈光不正有助於適當的治療,這無疑將推動對先進眼科設備的需求。
市場限制因子
發展中國家面臨的主要挑戰包括對定期眼科檢查的認知不足以及經濟能力有限。正如 Bimedis (2025) 指出,自動驗光儀價格高昂,通常高達 25,000 美元,這使得小型診所難以負擔,從而減緩了其在成本敏感地區的市場滲透。一些國家缺乏訓練有素的眼科技術人員也是促使設備利用率低的原因之一。
市場機會
大型公司之間的策略聯盟正在加速創新。 2024 年 4 月,卡爾蔡司醫療科技公司收購了 D.O.R.C.,從而增強了其眼科工作流程和產品組合。預計此類聯盟將支援推出更先進的設備,包括便攜式和人工智慧系統,從而在 2032 年前創造強勁的成長機會。
市場趨勢
數位影像、人工智慧診斷、機器學習、自動對焦、雲端資料儲存和電子健康記錄 (EHR) 整合等技術創新正在改變整個產業。現代設備能夠捕捉高解析度角膜影像,檢測細微的解剖結構變化,並提供自動化結果,從而提高臨床準確性和效率。這些創新使自動角膜曲率計 (ARK) 成為現代眼科實踐中不可或缺的工具。
依產品類型
按便攜性
依適應症劃分
根據克利夫蘭診所估計,到2024年,遠視將佔最大的市場佔有率,影響全球4.6%的兒童和30.9%的成人。由於螢幕使用時間的增加,近視和散光的盛行率預計將顯著上升。
依最終使用者劃分
儘管由於手術量大,醫院在2024年仍將佔市場主導地位,但由於專業眼科診所的擴張,預計眼科診所將增長最快。
依地區劃分
北美
受美國和加拿大高滲透率的推動,預計到2024年,北美市場規模將達到2,440萬美元。糖尿病的高發生率和日益增長的眼部併發症正在推動對精準診斷工具的需求。
歐洲
由於嚴格的醫療器材監管和龐大的眼科醫師群體,歐洲市場保持強勁成長。截至2023年12月,英國共有3,377名註冊眼科醫師。
亞太地區
預計將以最高的複合年增長率成長。屈光不正病例的增加,例如南德里學齡兒童散光盛行率高達47.8%(2022年),正在推動先進診斷技術的需求。
拉丁美洲/中東/非洲
由於醫療保健投資,包括沙烏地阿拉伯耗資650億美元的 "2030願景" 健康計劃,預計將實現溫和成長。
The global autorefractor and keratometer market continues to expand steadily due to rising ophthalmic disorders, increasing adoption of diagnostic equipment, and strong technological advancements in eye-care devices. The market was valued at USD 69.7 million in 2024, is expected to reach USD 73.3 million in 2025, and is projected to surge to USD 107.1 million by 2032, reflecting strong growth across ophthalmic practices worldwide. North America led the market in 2024 with a 35% share, supported by advanced healthcare infrastructure and major players expanding their diagnostic portfolios.
Market Overview
Autorefractors and keratometers are essential ophthalmic diagnostic instruments used to measure refractive error and corneal curvature, respectively. Combined units, known as autorefractor-keratometers (ARKs), provide comprehensive vision assessment for hyperopia, myopia, astigmatism, and other refractive issues. Demand for these devices is steadily rising due to the global burden of vision disorders and increased emphasis on early detection.
The market is supported by leading manufacturers such as Topcon Corporation, Carl Zeiss Meditech AG, NIDEK CO., LTD., Canon Medical Systems, and EssilorLuxottica, all investing heavily in technology advancements and product expansion strategies.
Market Drivers
Growing Burden of Eye Disorders
The prevalence of ocular diseases such as astigmatism, hyperopia, and cataracts is accelerating. Lifestyle changes, increased screen time, and age-related degeneration contribute to a growing population requiring vision correction. According to NCBI (September 2023), nearly 50% of the global population is expected to have myopia by 2050, with 10% becoming highly myopic. This rising burden necessitates advanced eye-diagnostic solutions, boosting demand for autorefractors and keratometers.
Push for Early and Accurate Diagnosis
Governments and healthcare institutions are increasing investments in early detection programs to manage preventable blindness. Early refractive error screening allows timely treatment, positively raising the demand for advanced ophthalmic equipment.
Market Restraints
A key challenge in developing economies is limited awareness regarding regular eye examinations, combined with affordability issues. High-end autorefractors costing up to USD 25,000, as cited by Bimedis (2025), are often unaffordable for smaller clinics, slowing market penetration in cost-sensitive regions. The lack of trained ophthalmic technicians in several countries also reduces device utilization.
Market Opportunities
Strategic collaborations among major players are accelerating innovation. In April 2024, Carl Zeiss Meditech acquired D.O.R.C., strengthening its ophthalmic workflow and product portfolio. Such partnerships support the launch of more advanced devices, including handheld and AI-enabled systems, creating strong growth opportunities through 2032.
Market Trends
Technological advancements-including digital imaging, AI-powered diagnostics, machine learning, automated focusing, cloud data storage, and EHR integration-are reshaping the industry. Modern devices can capture high-resolution corneal images, detect subtle anatomical changes, and provide automated results, improving clinical accuracy and efficiency. These innovations are positioning ARKs as indispensable tools in modern eye-care practices.
By Product Type
By Portability
By Indication
Hyperopia held the largest share in 2024, with Cleveland Clinic estimating it affects 4.6% of children and 30.9% of adults globally. Myopia and astigmatism are expected to grow significantly due to increased screen exposure.
By End User
Hospitals dominated in 2024 due to high procedure volume, while ophthalmic clinics are growing fastest with the expansion of specialty eye-care centers.
Regional Overview
North America
The region generated USD 24.4 million in 2024, driven by strong adoption in the U.S. and Canada. High diabetic population rates and increased ocular complications are pushing demand for precision diagnostic tools.
Europe
Europe maintains a strong market due to strict medical device regulations and a large ophthalmologist base. The U.K. had 3,377 ophthalmologists registered in December 2023.
Asia Pacific
Expected to grow at the fastest CAGR. Rising cases of refractive errors-such as 47.8% astigmatism in South Delhi school children (2022)-are driving demand for advanced diagnostics.
Latin America & Middle East/Africa
Moderate growth driven by healthcare investments, including Saudi Arabia's USD 65B Vision 2030 health program.
Conclusion
With a rise from USD 69.7 million (2024) to USD 107.1 million by 2032, the autorefractor and keratometer market is poised for strong, sustained growth. Increasing ocular diseases, technological advancements, and expanding healthcare infrastructure worldwide will continue to propel the market through the forecast period.
Segmentation By Product Type
By Portability
By Indication
By End-user
By Region